Gabapentin
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Gabapentin
Description:
Gabapentin is a potent, orally active P/Q type Ca2+ channel blocker. Gabapentin inhibits neuronal Ca2+ influx and reduction of neurotransmitter release. Gabapentin is a GABA analog that can be used to relieve neuropathic pain[1][2][3].UNSPSC:
12352211Hazard Statement:
H315, H319, H335, H360Target:
Calcium ChannelType:
Reference compoundRelated Pathways:
Membrane Transporter/Ion Channel; Neuronal SignalingApplications:
Neuroscience-NeuromodulationField of Research:
Neurological Disease; CancerAssay Protocol:
https://www.medchemexpress.com/Gabapentin.htmlPurity:
99.49Solubility:
DMSO : 1 mg/mL (ultrasonic) |H2O : 50 mg/mL (ultrasonic)Smiles:
O=C(O)CC1(CN)CCCCC1Molecular Formula:
C9H17NO2Molecular Weight:
171.24Precautions:
H315, H319, H335, H360References & Citations:
[1]Fink K, et, al. Inhibition of neuronal Ca (2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Br J Pharmacol. 2000 Jun;130 (4) :900-6.|[2]Celikyurt IK, et, al. Gabapentin, A GABA analogue, enhances cognitive performance in mice. Neurosci Lett. 2011 Apr 1;492 (2) :124-8.|[3]Meymandi MS, et, al. Gabapentin action and interaction on the antinociceptive effect of morphine on visceral pain in mice. Eur J Anaesthesiol. 2008 Feb;25 (2) :129-34.Shipping Conditions:
Room TemperatureStorage Conditions:
Store at room temperature 3 yearsScientific Category:
Reference compound1Clinical Information:
LaunchedCitation 01:
ACS Pharmacol Transl Sci. 2023 Mar 6;6 (4) :519-525.|Br J Pharmacol. 2025 Aug 9.|Cell Rep. 2019 Dec 17;29 (12) :3847-3858.e5.|iScience. 2023 Jul 3;26 (8) :107264.|J Nat Med. 2022 Jan;76 (1) :268-275.|J Pain. 2019 May;20 (5) :577-591. |Mol Biol Rep. 2025 Sep 3;52 (1) :859.|Neuropharmacology. 2024 Dec 21:110276.|Pharmacol Res Perspect. 2021 Oct;9 (5) :e00879.|Sci Total Environ. 2022 Jul 10;829:154437.|Eur J Drug Metab Pharmacokinet. 2022 Sep;47 (5) :639-652.CAS Number:
[60142-96-3]
